Catalent brings in Berkeley Lights to optimise cell lines
Catalent has agreed a deal to apply Berkeley Lights’ Beacon optofluidic platform to its cell lines.
Archives for July 18, 2018
US FDA targets endpoints, preclinical testing and trial design to advance gene therapies
The US FDA has released draft guidance documents on gene therapy programmes, which “should help sponsors avoid expending time and resources on unproductive drug development efforts,” says expert.
EU-Japan extend mutual recognition to biologics and APIs
The EU and Japan have extended their current mutual recognition agreement to include certain biologic medicines, sterile medicines and APIs.